<p>Option Care Health (OPCH) 最近表现强劲，过去一个月股价上涨约 10%，今年以来上涨超过 40%，超过了许多医疗行业的同行。</p>
<p>请查看我们对 Option Care Health 的最新分析。</p>
<p>这种背景符合更广泛的趋势，Option Care Health 年初至今的股价回报约为 43%，以及稳健的多年总股东回报表明，随着投资者重新评估其增长和风险特征，势头仍在增强。</p>
<p>如果 Option Care 的表现让你重新考虑医疗行业的投资，可能是时候看看其他医疗股票的表现，并比较机会。</p>
<p>然而，考虑到股价目前接近分析师的目标，并且交易价格高于许多历史估值标准，关键问题是 Option Care Health 是否仍然提供上涨空间，还是市场已经在定价其未来增长。</p>
<h2>最受欢迎的叙述：11% 低估</h2>
<p>Option Care Health 最近收盘价为 32.51 美元，而叙述的公允价值约为 36.45 美元，这使得估值案例倾向于进一步上涨，并将其增长驱动因素置于显微镜下。</p>
<blockquote>
<p><em>公司全国业务范围的持续扩展和先进的从业者模式正在提高护士的生产力，使得能够治疗更高严重程度、复杂和新的治疗群体（包括肿瘤学和阿尔茨海默病），推动利润率改善和新的收入来源。</em></p>
</blockquote>
<p>阅读完整的叙述。</p>
<p>想知道这种规模扩展意味着什么样的收益增长吗？叙述依赖于上升的利润率、复合收入和溢价的未来收益倍数。好奇这些杠杆如何支持更高的公允价值吗？</p>
<p><strong>结果：公允价值为 36.45 美元（低估）</strong></p>
<p>完整阅读叙述，了解预测背后的原因。</p>
<p>然而，治疗组合的变化和潜在的报销压力可能会迅速压缩利润率，这可能限制收益增长并挑战乐观的估值叙述。</p>
<p>了解 Option Care Health 叙述的关键风险。</p>
<h2>自建 Option Care Health 叙述</h2>
<p>如果你对这个故事有不同的看法或想自己深入研究数字，可以在几分钟内构建一个自定义视图：按你的方式进行。</p>
<p>你对 Option Care Health 研究的一个很好的起点是我们的分析，强调了 3 个关键收益和 1 个可能影响你投资决策的重要警示。</p>
<h2>寻找更多投资想法？</h2>
<p>在你继续之前，探索一些来自 Simply Wall St 筛选器的新机会，以免你成为那个看着别人获取收益的人。</p>
<ul>
<li>通过针对这些 898 只基于未来现金流和基本面的低估股票，利用错误定价的优质公司。</li>
<li>通过关注这 24 只在变革性软件和现实需求交汇处的 AI 便士股票，探索下一波创新。</li>
<li>通过关注这些 12 只收益率超过 3% 的股息股票，增强你的收入流，这些股票在收益和可持续支付潜力之间取得平衡。</li>
</ul>
<p><em>这篇文章由 Simply Wall St 撰写，性质上是一般性的。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成购买或出售任何股票的推荐，也未考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
<p>移动基础设施用于国防和灾难</p>
<p>下一波机器人技术不是类人机器人，而是能够在 30 分钟内在任何地方提供 5G、ISR 和雷达的全自动塔。</p>
<p>在下一轮合同之前获取投资者简报</p>
<p>由 CiTech 赞助</p>

拜尔斯普保健

<p>Option Care Health (OPCH) 的股票在过去一个月上涨了 10%，今年以来上涨超过 40%。分析师认为该股票被低估了 11%，合理价值为 36.45 美元。公司的扩张和先进的从业者模式正在推动收入和利润率的改善。然而，风险包括治疗组合的变化和报销压力。投资者被鼓励进一步探索医疗保健股票和其他被低估行业的机会</p>

<p>Option Care Health (OPCH) has quietly put together a strong run, with the stock up around 10% over the past month and more than 40% this year, outpacing many healthcare peers.</p>
<div class="lb-trans"><p>Option Care Health (OPCH) 最近表现强劲，过去一个月股价上涨约 10%，今年以来上涨超过 40%，超过了许多医疗行业的同行。</p>
</div><p>See our latest analysis for Option Care Health.</p>
<div class="lb-trans"><p>请查看我们对 Option Care Health 的最新分析。</p>
</div><p>That backdrop fits a broader pattern, with Option Care Health’s roughly 43% year to date share price return and solid multi year total shareholder returns suggesting that momentum is still building as investors reassess its growth and risk profile.</p>
<div class="lb-trans"><p>这种背景符合更广泛的趋势，Option Care Health 年初至今的股价回报约为 43%，以及稳健的多年总股东回报表明，随着投资者重新评估其增长和风险特征，势头仍在增强。</p>
</div><p>If Option Care’s run has you rethinking healthcare exposure, it might be a good moment to see what else is working across healthcare stocks and compare opportunities.</p>
<div class="lb-trans"><p>如果 Option Care 的表现让你重新考虑医疗行业的投资，可能是时候看看其他医疗股票的表现，并比较机会。</p>
</div><p>Yet with shares now near analysts’ targets and trading above many historical valuation marks, the key question is whether Option Care Health still offers upside or if the market is already pricing in its future growth.</p>
<div class="lb-trans"><p>然而，考虑到股价目前接近分析师的目标，并且交易价格高于许多历史估值标准，关键问题是 Option Care Health 是否仍然提供上涨空间，还是市场已经在定价其未来增长。</p>
</div><h2>Most Popular Narrative Narrative: 11% Undervalued</h2>
<div class="lb-trans"><h2>最受欢迎的叙述：11% 低估</h2>
</div><p>With Option Care Health last closing at $32.51 against a narrative fair value of about $36.45, the valuation case leans toward further upside and puts its growth drivers under the microscope.</p>
<div class="lb-trans"><p>Option Care Health 最近收盘价为 32.51 美元，而叙述的公允价值约为 36.45 美元，这使得估值案例倾向于进一步上涨，并将其增长驱动因素置于显微镜下。</p>
</div><blockquote>
<p><em>Continued expansion of the company's national suite footprint and advanced practitioner model is improving nurse productivity and enabling the treatment of higher acuity, complex, and new therapeutic cohorts (including oncology and Alzheimer's), driving both margin improvements and new revenue streams.</em></p>
</blockquote>
<div class="lb-trans"><blockquote>
<p><em>公司全国业务范围的持续扩展和先进的从业者模式正在提高护士的生产力，使得能够治疗更高严重程度、复杂和新的治疗群体（包括肿瘤学和阿尔茨海默病），推动利润率改善和新的收入来源。</em></p>
</blockquote>
</div><p>Read the complete narrative.</p>
<div class="lb-trans"><p>阅读完整的叙述。</p>
</div><p>Want to see what kind of earnings expansion this scale up implies? The narrative leans on rising margins, compounding revenue, and a premium future earnings multiple. Curious how those levers stack up to support that higher fair value?</p>
<div class="lb-trans"><p>想知道这种规模扩展意味着什么样的收益增长吗？叙述依赖于上升的利润率、复合收入和溢价的未来收益倍数。好奇这些杠杆如何支持更高的公允价值吗？</p>
</div><p><strong>Result: Fair Value of $36.45 (UNDERVALUED)</strong></p>
<div class="lb-trans"><p><strong>结果：公允价值为 36.45 美元（低估）</strong></p>
</div><p>Have a read of the narrative in full and understand what's behind the forecasts.</p>
<div class="lb-trans"><p>完整阅读叙述，了解预测背后的原因。</p>
</div><p>However, shifting therapy mix and potential reimbursement pressure could quickly compress margins, which may limit earnings expansion and challenge the upbeat valuation narrative.</p>
<div class="lb-trans"><p>然而，治疗组合的变化和潜在的报销压力可能会迅速压缩利润率，这可能限制收益增长并挑战乐观的估值叙述。</p>
</div><p>Find out about the key risks to this Option Care Health narrative.</p>
<div class="lb-trans"><p>了解 Option Care Health 叙述的关键风险。</p>
</div><h2>Build Your Own Option Care Health Narrative</h2>
<div class="lb-trans"><h2>自建 Option Care Health 叙述</h2>
</div><p>If you see the story differently or want to dig into the numbers yourself, you can build a custom view in just minutes: Do it your way.</p>
<div class="lb-trans"><p>如果你对这个故事有不同的看法或想自己深入研究数字，可以在几分钟内构建一个自定义视图：按你的方式进行。</p>
</div><p>A great starting point for your Option Care Health research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.</p>
<div class="lb-trans"><p>你对 Option Care Health 研究的一个很好的起点是我们的分析，强调了 3 个关键收益和 1 个可能影响你投资决策的重要警示。</p>
</div><h2>Looking for more investment ideas?</h2>
<div class="lb-trans"><h2>寻找更多投资想法？</h2>
</div><p>Before you move on, explore a few fresh opportunities from the Simply Wall St Screener so you are not the one watching others capture the upside.</p>
<div class="lb-trans"><p>在你继续之前，探索一些来自 Simply Wall St 筛选器的新机会，以免你成为那个看着别人获取收益的人。</p>
</div><ul>
<li>Capitalize on mispriced quality by targeting companies screened as these 898 undervalued stocks based on cash flows based on their future cash flows and fundamentals.</li>
<li>Explore the next wave of innovation by focusing on these 24 AI penny stocks at the intersection of transformational software and real world demand.</li>
<li>Strengthen your income stream by zeroing in on these 12 dividend stocks with yields &gt; 3% that balance yield with sustainable payout potential.</li>
</ul>
<div class="lb-trans"><ul>
<li>通过针对这些 898 只基于未来现金流和基本面的低估股票，利用错误定价的优质公司。</li>
<li>通过关注这 24 只在变革性软件和现实需求交汇处的 AI 便士股票，探索下一波创新。</li>
<li>通过关注这些 12 只收益率超过 3% 的股息股票，增强你的收入流，这些股票在收益和可持续支付潜力之间取得平衡。</li>
</ul>
</div><p><em>This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.</em></p>
<div class="lb-trans"><p><em>这篇文章由 Simply Wall St 撰写，性质上是一般性的。<strong>我们提供基于历史数据和分析师预测的评论，仅使用无偏见的方法，我们的文章并不旨在提供财务建议。</strong> 这并不构成购买或出售任何股票的推荐，也未考虑你的目标或财务状况。我们旨在为你提供以基本数据驱动的长期分析。请注意，我们的分析可能未考虑最新的价格敏感公司公告或定性材料。Simply Wall St 在提到的任何股票中没有持仓。</em></p>
</div><p>Mobile Infrastructure for Defense and Disaster</p>
<div class="lb-trans"><p>移动基础设施用于国防和灾难</p>
</div><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p>
<div class="lb-trans"><p>下一波机器人技术不是类人机器人，而是能够在 30 分钟内在任何地方提供 5G、ISR 和雷达的全自动塔。</p>
</div><p>Get the investor briefing before the next round of contracts</p>
<div class="lb-trans"><p>在下一轮合同之前获取投资者简报</p>
</div><p>Sponsored On Behalf of CiTech</p>
<div class="lb-trans"><p>由 CiTech 赞助</p>
</div>

拜尔斯普保健（Option Care Health，OPCH）：市场是否低估了这只被低估 11% 的医疗保健股的增长势头？